Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Muscle Wasting Disorders Market Expansion From $19.96 Billion In 2026 To $33.49 Billion In 2030
The market for muscle wasting disorders experienced substantial expansion lately, with projections indicating continued growth from $17.49 billion in 2025 to $19.96 billion by 2026, reflecting a compound annual growth rate of 14.2%. This upward trajectory during the past years is largely a consequence of factors such as the increased incidence of conditions like muscular dystrophy and ALS, a greater reliance on physical therapy modalities, heightened consumption of nutritional supplements, the proactive implementation of anti-inflammatory therapies, and an expansion in hospital-based rehabilitation services.
The market for muscle wasting disorders is poised for substantial expansion in the coming years, projected to reach $33.5 billion by 2030 with a compound annual growth rate of 13.8%. This anticipated growth trajectory is fueled by a confluence of factors, including significant progress in gene therapy, escalating investments in regenerative medicine, the proliferation of specialized rehabilitation facilities, a heightened demand for tailored treatment strategies, and a growing emphasis on dietary interventions. Key developments anticipated during this forecast period encompass the increasing embrace of gene therapy for muscle repair, a surge in the utilization of nutritional supplements and proteins, a greater need for physical rehabilitation programs, the broadening scope of targeted therapies for muscular dystrophy, and a more extensive application of hormonal and anti-inflammatory drug treatments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp
Muscle Wasting Disorders Market Expansion Drivers: What Is Shaping Future Growth?
The increasing adoption of inactive lifestyles is anticipated to be a primary driver for the expansion of the muscle wasting disorders market. Such lifestyles are characterized by minimal physical activity and a lack of exercise, which can detrimentally affect muscular capabilities, resulting in diminished strength and endurance. This decline contributes to the development of muscle wasting conditions, making it harder for people to preserve their muscle mass and functionality. Illustratively, data from NHS England revealed that in March 2025, over a quarter of adults were categorized as inactive, and in 2023, nearly a third of children and young people (30.2 percent) managed less than 30 minutes of physical activity each day. Consequently, this growing trend towards sedentary behavior is fueling the growth of the market for muscle wasting disorder treatments and solutions.
Muscle Wasting Disorders Market Segment Analysis Highlighting Growth Areas
The muscle wasting disorders market covered in this report is segmented –
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices
Muscle Wasting Disorders Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Within the market for muscle wasting disorders, leading enterprises are actively engaged in pioneering new treatments, including advanced gene therapy solutions, to enhance care for individuals affected by these conditions. This sophisticated gene therapy approach involves employing medical technology focused on modifying gene expression or altering the inherent biological characteristics of live cells to achieve a beneficial therapeutic outcome. A notable development occurred in June 2023 when Sarepta Therapeutics, a biotechnology firm headquartered in the United States, unveiled Elevidys, marking the U.S. Food and Drug Administration’s (FDA) inaugural approval of a gene therapy specifically for treating Duchenne muscular dystrophy (DMD) in children aged 4 to 5 years. Elevidys functions as a recombinant gene therapy, engineered to introduce a gene into the body responsible for producing a truncated protein that encompasses key segments of the dystrophin protein found in healthy muscle cells; this treatment is administered through a single intravenous infusion.
Muscle Wasting Disorders Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the muscle wasting disorders market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Cytokinetics Incorporated, Scholar Rock, Akashi Therapeutics, aTyr Pharma, MyoTherix Inc., Pephexia Therapeutics, Biophytis SA, TNF Pharmaceuticals Inc., Rejuvenate Biomed, Edgewise Therapeutics
Access The Complete Muscle Wasting Disorders Market Report:
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report
Muscle Wasting Disorders Market Regional Analysis And Leading Geography
North Americawas the largest region in the muscle wasting disorder market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
